← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2012Last known activity
Nov 11, 2020
Defunct as of Jun 22, 2022
Timeline
2000s
- Jun 1, 2006
Genocea Biosciences, Inc.— Founded
2020s
- Jun 22, 2022
Genocea Biosciences, Inc.— Defunct
Drugs by trial phase (12 distinct, 9 trials)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Carcinoma
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Communicable Diseases
- Herpes Genitalis
- Herpes Simplex
- Herpesviridae Infections
- Infections
- Lung Neoplasms
- Melanoma
- Pneumococcal Infections
- Pneumonia
- Pneumonia, Pneumococcal
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
Recent trials (10)
- NCT04596033Study directorPhase 1Nov 11, 2020
- NCT04596033Lead sponsorPhase 1Nov 11, 2020
- NCT03633110Lead sponsorPhase 1/Phase 2Aug 29, 2018
- NCT03146403Lead sponsorPhase 2May 24, 2017
- NCT02515175Lead sponsorPhase 2Nov 1, 2015
- NCT02300142Lead sponsorPhase 2Jan 1, 2015
- NCT02116998Lead sponsorPhase 2Sep 1, 2014
- NCT02114060Lead sponsorPhase 2Jul 1, 2014
- NCT01995617Lead sponsorPhase 1Nov 1, 2013
- NCT01667341Lead sponsorPhase 1/Phase 2Jul 1, 2012
Details
- Founded
- Cambridge, MA, US Jun 1, 2006
- Last known activity
- Nov 11, 2020